GL1X · GenesisL1 explorer

MolNFT v1 · #117257 · protein

Factor xia in complex with the inhibitor 4-[(N-{(2E)-3-[5-chloro-2- (1H-tetrazol-1-YL)PHENYL]PROP-2-enoyl}-L-PHENYLALANYL)AMINO]BENZOIC acid

5E2O · Coagulation factor xia light chain: “Factor xia in complex with the inhibitor 4-[(N-{(2E)-3-[5-chloro-2…”. X-ray diffraction, 2 ligands (5JM, SO4), 2 pockets (best druggability 0.44). MolNFT v1 #117257 on GenesisL1: 3D structure…

PDB
5E2O
Type
protein
Length
238 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Coagulation factor xia light chain
EC
3.4.21.27
UniProt
P03951
Ligands
5JM, SO4
Pockets
2 · best druggability 0.44

Structure

x-ray diffraction · 1 distinct chain · 15% helix, 34% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACoagulation factor xia light chain (EC 3.4.21.27)protein23815% helix, 34% strandP03951

Ligands and binding sites

  • 5JM · 4-[(N-{(2E)-3-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]prop-2-enoyl}-L-phenylalanyl)amino]benzoic acid · ligand · chains A
  • SO4 · Sulfate ion · ion · 2 copies · chains A
  • EDO · 1,2-ethanediol · additive · 9 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11440.440.76225JM, EDO
21080.410.7622empty

Modifications

Observed in the structure: 4 disulfide (disulfide).

Compared structures

  • 5E2O · FACTOR XIA IN COMPLEX WITH THE INHIBITOR 4-[(N-{(2E)-3-[5-chloro-2-(1H-tetrazol-1-yl)pheny… · the same entry in another collection · chain A against A, TM-score 1.00
  • P03951 · AlphaFold monomer V2.0 prediction for coagulation factor XI (P03951) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.